Global Pharmaceutical Isolator
Global Pharmaceutical Isolator

Pharmaceutical Isolator Comprehensive Study by Type (Open Isolator, Closed Isolator), Application (Aseptic Filling, Fluid Dispensing, Sampling/Weighing/Distribution, Product Containment, Others), Product Class (Class III, ISO Class 5), Configuration (Floor-standing, Modular, Mobile, Compact, Tabletop, Portable), Pressure (Positive Pressure, Negative Pressure), End User (Pharmaceutical & Biotechnology Companies, Hospitals, Research & Academic Laboratories, Others) Players and Region - Global Market Outlook to 2026

Pharmaceutical Isolator Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Mar 2021 Edition 223 Pages 171 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Pharmaceutical Isolator Market?

Pharmaceutical Isolators are used for product testing, processing and filling. This includes integration with filling machines, freeze dryers, autoclaves, and decontamination systems. The improvement in drug quality, the capability of longer production runs, and the reduction of operating costs are significant advantages in comparison to conventional cleanroom production. Isolators will eliminate the need for PPE and reduce the number of medical exams for operators. The majority of the pharmaceutical isolators are built and introduced in the market as per the manufacturing or research facility’s requirements.

The market study is being classified by Type (Open Isolator and Closed Isolator), by Application (Aseptic Filling, Fluid Dispensing, Sampling/Weighing/Distribution, Product Containment and Others) and major geographies with country level break-up.

SKAN AG (Switzerland), Azbil Telstar (India), VanRx Pharmasystems Inc. (Canada), NuAire Inc. (United States), Schematic Engineering Industries (India), MBRAUN (Germany), Robert Bosch GmbH (Germany), Hosokawa Micron Ltd (Japan), Fedegari Autoclavi SpA (Italy), LAF Technologies Pty Ltd. (Australia) and IsoTech Design (Canada) are some of the key players profiled in the study. Additionally, the Manufacturers which are also part of the research are Comecer (Italy) and Gelman Singapore Pte Ltd. (Singapore).

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. Research Analyst at AMA predicts that Global Manufacturers will contribute to the maximum growth of Global Pharmaceutical Isolator market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Pharmaceutical Isolator market by Type, Application and Region.

On the basis of geography, the market of Pharmaceutical Isolator has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Pharmaceutical Industry and Drug Manufacturing
  • Increasing Expenditure on Research and Development

Market Trend
  • Launch and Addition of New Products using Pharmaceutical Isolators

Restraints
  • High Cost associated with the Installation

Opportunities
  • Strict Government Regulatory Policies to Maintain Safety and Efficacy of the Drug
  • Growing Investment in the Pharmaceutical Isolators by the Key Player

Challenges
  • Maintenance of Pharmaceutical Isolators


In May 2018, COMECER SpA along with its US-based subsidiary, Comecer America, announced a collaboration with Advaxis to produce an aseptic manufacturing system (isolation technology).


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Pharmaceutical Isolator Manufacturers, Pharmaceutical Isolator Suppliers/Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Open Isolator
  • Closed Isolator
By Application
  • Aseptic Filling
  • Fluid Dispensing
  • Sampling/Weighing/Distribution
  • Product Containment
  • Others
By Product Class
  • Class III
  • ISO Class 5

By Configuration
  • Floor-standing
  • Modular
  • Mobile
  • Compact
  • Tabletop
  • Portable

By Pressure
  • Positive Pressure
  • Negative Pressure

By End User
  • Pharmaceutical & Biotechnology Companies
  • Hospitals
  • Research & Academic Laboratories
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Pharmaceutical Industry and Drug Manufacturing
      • 3.2.2. Increasing Expenditure on Research and Development
    • 3.3. Market Challenges
      • 3.3.1. Maintenance of Pharmaceutical Isolators
    • 3.4. Market Trends
      • 3.4.1. Launch and Addition of New Products using Pharmaceutical Isolators
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmaceutical Isolator, by Type, Application, Product Class, Configuration, Pressure, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pharmaceutical Isolator (Value)
      • 5.2.1. Global Pharmaceutical Isolator by: Type (Value)
        • 5.2.1.1. Open Isolator
        • 5.2.1.2. Closed Isolator
      • 5.2.2. Global Pharmaceutical Isolator by: Application (Value)
        • 5.2.2.1. Aseptic Filling
        • 5.2.2.2. Fluid Dispensing
        • 5.2.2.3. Sampling/Weighing/Distribution
        • 5.2.2.4. Product Containment
        • 5.2.2.5. Others
      • 5.2.3. Global Pharmaceutical Isolator by: Product Class (Value)
        • 5.2.3.1. Class III
        • 5.2.3.2. ISO Class 5
      • 5.2.4. Global Pharmaceutical Isolator by: Configuration (Value)
        • 5.2.4.1. Floor-standing
        • 5.2.4.2. Modular
        • 5.2.4.3. Mobile
        • 5.2.4.4. Compact
        • 5.2.4.5. Tabletop
        • 5.2.4.6. Portable
      • 5.2.5. Global Pharmaceutical Isolator by: Pressure (Value)
        • 5.2.5.1. Positive Pressure
        • 5.2.5.2. Negative Pressure
      • 5.2.6. Global Pharmaceutical Isolator by: End User (Value)
        • 5.2.6.1. Pharmaceutical & Biotechnology Companies
        • 5.2.6.2. Hospitals
        • 5.2.6.3. Research & Academic Laboratories
        • 5.2.6.4. Others
      • 5.2.7. Global Pharmaceutical Isolator Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Taiwan
          • 5.2.7.2.6. Australia
          • 5.2.7.2.7. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
    • 5.3. Global Pharmaceutical Isolator (Volume)
      • 5.3.1. Global Pharmaceutical Isolator by: Type (Volume)
        • 5.3.1.1. Open Isolator
        • 5.3.1.2. Closed Isolator
      • 5.3.2. Global Pharmaceutical Isolator by: Application (Volume)
        • 5.3.2.1. Aseptic Filling
        • 5.3.2.2. Fluid Dispensing
        • 5.3.2.3. Sampling/Weighing/Distribution
        • 5.3.2.4. Product Containment
        • 5.3.2.5. Others
      • 5.3.3. Global Pharmaceutical Isolator by: Product Class (Volume)
        • 5.3.3.1. Class III
        • 5.3.3.2. ISO Class 5
      • 5.3.4. Global Pharmaceutical Isolator by: Configuration (Volume)
        • 5.3.4.1. Floor-standing
        • 5.3.4.2. Modular
        • 5.3.4.3. Mobile
        • 5.3.4.4. Compact
        • 5.3.4.5. Tabletop
        • 5.3.4.6. Portable
      • 5.3.5. Global Pharmaceutical Isolator by: Pressure (Volume)
        • 5.3.5.1. Positive Pressure
        • 5.3.5.2. Negative Pressure
      • 5.3.6. Global Pharmaceutical Isolator by: End User (Volume)
        • 5.3.6.1. Pharmaceutical & Biotechnology Companies
        • 5.3.6.2. Hospitals
        • 5.3.6.3. Research & Academic Laboratories
        • 5.3.6.4. Others
      • 5.3.7. Global Pharmaceutical Isolator Region
        • 5.3.7.1. South America
          • 5.3.7.1.1. Brazil
          • 5.3.7.1.2. Argentina
          • 5.3.7.1.3. Rest of South America
        • 5.3.7.2. Asia Pacific
          • 5.3.7.2.1. China
          • 5.3.7.2.2. Japan
          • 5.3.7.2.3. India
          • 5.3.7.2.4. South Korea
          • 5.3.7.2.5. Taiwan
          • 5.3.7.2.6. Australia
          • 5.3.7.2.7. Rest of Asia-Pacific
        • 5.3.7.3. Europe
          • 5.3.7.3.1. Germany
          • 5.3.7.3.2. France
          • 5.3.7.3.3. Italy
          • 5.3.7.3.4. United Kingdom
          • 5.3.7.3.5. Netherlands
          • 5.3.7.3.6. Rest of Europe
        • 5.3.7.4. MEA
          • 5.3.7.4.1. Middle East
          • 5.3.7.4.2. Africa
        • 5.3.7.5. North America
          • 5.3.7.5.1. United States
          • 5.3.7.5.2. Canada
          • 5.3.7.5.3. Mexico
    • 5.4. Global Pharmaceutical Isolator (Price)
      • 5.4.1. Global Pharmaceutical Isolator by: Type (Price)
  • 6. Pharmaceutical Isolator: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. SKAN AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Azbil Telstar (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. VanRx Pharmasystems Inc. (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. NuAire Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Schematic Engineering Industries (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. MBRAUN (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Robert Bosch GmbH (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Hosokawa Micron Ltd (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Fedegari Autoclavi SpA (Italy)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. LAF Technologies Pty Ltd. (Australia)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. IsoTech Design (Canada)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Pharmaceutical Isolator Sale, by Type, Application, Product Class, Configuration, Pressure, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pharmaceutical Isolator (Value)
      • 7.2.1. Global Pharmaceutical Isolator by: Type (Value)
        • 7.2.1.1. Open Isolator
        • 7.2.1.2. Closed Isolator
      • 7.2.2. Global Pharmaceutical Isolator by: Application (Value)
        • 7.2.2.1. Aseptic Filling
        • 7.2.2.2. Fluid Dispensing
        • 7.2.2.3. Sampling/Weighing/Distribution
        • 7.2.2.4. Product Containment
        • 7.2.2.5. Others
      • 7.2.3. Global Pharmaceutical Isolator by: Product Class (Value)
        • 7.2.3.1. Class III
        • 7.2.3.2. ISO Class 5
      • 7.2.4. Global Pharmaceutical Isolator by: Configuration (Value)
        • 7.2.4.1. Floor-standing
        • 7.2.4.2. Modular
        • 7.2.4.3. Mobile
        • 7.2.4.4. Compact
        • 7.2.4.5. Tabletop
        • 7.2.4.6. Portable
      • 7.2.5. Global Pharmaceutical Isolator by: Pressure (Value)
        • 7.2.5.1. Positive Pressure
        • 7.2.5.2. Negative Pressure
      • 7.2.6. Global Pharmaceutical Isolator by: End User (Value)
        • 7.2.6.1. Pharmaceutical & Biotechnology Companies
        • 7.2.6.2. Hospitals
        • 7.2.6.3. Research & Academic Laboratories
        • 7.2.6.4. Others
      • 7.2.7. Global Pharmaceutical Isolator Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Taiwan
          • 7.2.7.2.6. Australia
          • 7.2.7.2.7. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
    • 7.3. Global Pharmaceutical Isolator (Volume)
      • 7.3.1. Global Pharmaceutical Isolator by: Type (Volume)
        • 7.3.1.1. Open Isolator
        • 7.3.1.2. Closed Isolator
      • 7.3.2. Global Pharmaceutical Isolator by: Application (Volume)
        • 7.3.2.1. Aseptic Filling
        • 7.3.2.2. Fluid Dispensing
        • 7.3.2.3. Sampling/Weighing/Distribution
        • 7.3.2.4. Product Containment
        • 7.3.2.5. Others
      • 7.3.3. Global Pharmaceutical Isolator by: Product Class (Volume)
        • 7.3.3.1. Class III
        • 7.3.3.2. ISO Class 5
      • 7.3.4. Global Pharmaceutical Isolator by: Configuration (Volume)
        • 7.3.4.1. Floor-standing
        • 7.3.4.2. Modular
        • 7.3.4.3. Mobile
        • 7.3.4.4. Compact
        • 7.3.4.5. Tabletop
        • 7.3.4.6. Portable
      • 7.3.5. Global Pharmaceutical Isolator by: Pressure (Volume)
        • 7.3.5.1. Positive Pressure
        • 7.3.5.2. Negative Pressure
      • 7.3.6. Global Pharmaceutical Isolator by: End User (Volume)
        • 7.3.6.1. Pharmaceutical & Biotechnology Companies
        • 7.3.6.2. Hospitals
        • 7.3.6.3. Research & Academic Laboratories
        • 7.3.6.4. Others
      • 7.3.7. Global Pharmaceutical Isolator Region
        • 7.3.7.1. South America
          • 7.3.7.1.1. Brazil
          • 7.3.7.1.2. Argentina
          • 7.3.7.1.3. Rest of South America
        • 7.3.7.2. Asia Pacific
          • 7.3.7.2.1. China
          • 7.3.7.2.2. Japan
          • 7.3.7.2.3. India
          • 7.3.7.2.4. South Korea
          • 7.3.7.2.5. Taiwan
          • 7.3.7.2.6. Australia
          • 7.3.7.2.7. Rest of Asia-Pacific
        • 7.3.7.3. Europe
          • 7.3.7.3.1. Germany
          • 7.3.7.3.2. France
          • 7.3.7.3.3. Italy
          • 7.3.7.3.4. United Kingdom
          • 7.3.7.3.5. Netherlands
          • 7.3.7.3.6. Rest of Europe
        • 7.3.7.4. MEA
          • 7.3.7.4.1. Middle East
          • 7.3.7.4.2. Africa
        • 7.3.7.5. North America
          • 7.3.7.5.1. United States
          • 7.3.7.5.2. Canada
          • 7.3.7.5.3. Mexico
    • 7.4. Global Pharmaceutical Isolator (Price)
      • 7.4.1. Global Pharmaceutical Isolator by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmaceutical Isolator: by Type(USD Million)
  • Table 2. Pharmaceutical Isolator Open Isolator , by Region USD Million (2015-2020)
  • Table 3. Pharmaceutical Isolator Closed Isolator , by Region USD Million (2015-2020)
  • Table 4. Pharmaceutical Isolator: by Application(USD Million)
  • Table 5. Pharmaceutical Isolator Aseptic Filling , by Region USD Million (2015-2020)
  • Table 6. Pharmaceutical Isolator Fluid Dispensing , by Region USD Million (2015-2020)
  • Table 7. Pharmaceutical Isolator Sampling/Weighing/Distribution , by Region USD Million (2015-2020)
  • Table 8. Pharmaceutical Isolator Product Containment , by Region USD Million (2015-2020)
  • Table 9. Pharmaceutical Isolator Others , by Region USD Million (2015-2020)
  • Table 10. Pharmaceutical Isolator: by Product Class(USD Million)
  • Table 11. Pharmaceutical Isolator Class III , by Region USD Million (2015-2020)
  • Table 12. Pharmaceutical Isolator ISO Class 5 , by Region USD Million (2015-2020)
  • Table 13. Pharmaceutical Isolator: by Configuration(USD Million)
  • Table 14. Pharmaceutical Isolator Floor-standing , by Region USD Million (2015-2020)
  • Table 15. Pharmaceutical Isolator Modular , by Region USD Million (2015-2020)
  • Table 16. Pharmaceutical Isolator Mobile , by Region USD Million (2015-2020)
  • Table 17. Pharmaceutical Isolator Compact , by Region USD Million (2015-2020)
  • Table 18. Pharmaceutical Isolator Tabletop , by Region USD Million (2015-2020)
  • Table 19. Pharmaceutical Isolator Portable , by Region USD Million (2015-2020)
  • Table 20. Pharmaceutical Isolator: by Pressure(USD Million)
  • Table 21. Pharmaceutical Isolator Positive Pressure , by Region USD Million (2015-2020)
  • Table 22. Pharmaceutical Isolator Negative Pressure , by Region USD Million (2015-2020)
  • Table 23. Pharmaceutical Isolator: by End User(USD Million)
  • Table 24. Pharmaceutical Isolator Pharmaceutical & Biotechnology Companies , by Region USD Million (2015-2020)
  • Table 25. Pharmaceutical Isolator Hospitals , by Region USD Million (2015-2020)
  • Table 26. Pharmaceutical Isolator Research & Academic Laboratories , by Region USD Million (2015-2020)
  • Table 27. Pharmaceutical Isolator Others , by Region USD Million (2015-2020)
  • Table 28. South America Pharmaceutical Isolator, by Country USD Million (2015-2020)
  • Table 29. South America Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 30. South America Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 31. South America Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 32. South America Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 33. South America Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 34. South America Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 35. Brazil Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 36. Brazil Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 37. Brazil Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 38. Brazil Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 39. Brazil Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 40. Brazil Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 41. Argentina Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 42. Argentina Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 43. Argentina Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 44. Argentina Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 45. Argentina Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 46. Argentina Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 47. Rest of South America Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 48. Rest of South America Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 49. Rest of South America Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 50. Rest of South America Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 51. Rest of South America Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 52. Rest of South America Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 53. Asia Pacific Pharmaceutical Isolator, by Country USD Million (2015-2020)
  • Table 54. Asia Pacific Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 55. Asia Pacific Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 56. Asia Pacific Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 57. Asia Pacific Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 58. Asia Pacific Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 59. Asia Pacific Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 60. China Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 61. China Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 62. China Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 63. China Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 64. China Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 65. China Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 66. Japan Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 67. Japan Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 68. Japan Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 69. Japan Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 70. Japan Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 71. Japan Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 72. India Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 73. India Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 74. India Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 75. India Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 76. India Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 77. India Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 78. South Korea Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 79. South Korea Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 80. South Korea Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 81. South Korea Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 82. South Korea Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 83. South Korea Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 84. Taiwan Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 85. Taiwan Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 86. Taiwan Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 87. Taiwan Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 88. Taiwan Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 89. Taiwan Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 90. Australia Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 91. Australia Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 92. Australia Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 93. Australia Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 94. Australia Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 95. Australia Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 96. Rest of Asia-Pacific Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 97. Rest of Asia-Pacific Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 98. Rest of Asia-Pacific Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 99. Rest of Asia-Pacific Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 100. Rest of Asia-Pacific Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 101. Rest of Asia-Pacific Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 102. Europe Pharmaceutical Isolator, by Country USD Million (2015-2020)
  • Table 103. Europe Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 104. Europe Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 105. Europe Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 106. Europe Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 107. Europe Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 108. Europe Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 109. Germany Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 110. Germany Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 111. Germany Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 112. Germany Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 113. Germany Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 114. Germany Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 115. France Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 116. France Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 117. France Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 118. France Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 119. France Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 120. France Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 121. Italy Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 122. Italy Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 123. Italy Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 124. Italy Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 125. Italy Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 126. Italy Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 127. United Kingdom Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 128. United Kingdom Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 129. United Kingdom Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 130. United Kingdom Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 131. United Kingdom Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 132. United Kingdom Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 133. Netherlands Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 134. Netherlands Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 135. Netherlands Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 136. Netherlands Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 137. Netherlands Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 138. Netherlands Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 139. Rest of Europe Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 140. Rest of Europe Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 141. Rest of Europe Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 142. Rest of Europe Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 143. Rest of Europe Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 144. Rest of Europe Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 145. MEA Pharmaceutical Isolator, by Country USD Million (2015-2020)
  • Table 146. MEA Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 147. MEA Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 148. MEA Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 149. MEA Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 150. MEA Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 151. MEA Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 152. Middle East Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 153. Middle East Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 154. Middle East Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 155. Middle East Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 156. Middle East Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 157. Middle East Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 158. Africa Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 159. Africa Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 160. Africa Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 161. Africa Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 162. Africa Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 163. Africa Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 164. North America Pharmaceutical Isolator, by Country USD Million (2015-2020)
  • Table 165. North America Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 166. North America Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 167. North America Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 168. North America Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 169. North America Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 170. North America Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 171. United States Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 172. United States Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 173. United States Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 174. United States Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 175. United States Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 176. United States Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 177. Canada Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 178. Canada Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 179. Canada Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 180. Canada Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 181. Canada Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 182. Canada Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 183. Mexico Pharmaceutical Isolator, by Type USD Million (2015-2020)
  • Table 184. Mexico Pharmaceutical Isolator, by Application USD Million (2015-2020)
  • Table 185. Mexico Pharmaceutical Isolator, by Product Class USD Million (2015-2020)
  • Table 186. Mexico Pharmaceutical Isolator, by Configuration USD Million (2015-2020)
  • Table 187. Mexico Pharmaceutical Isolator, by Pressure USD Million (2015-2020)
  • Table 188. Mexico Pharmaceutical Isolator, by End User USD Million (2015-2020)
  • Table 189. Pharmaceutical Isolator Sales: by Type(K Unit)
  • Table 190. Pharmaceutical Isolator Sales Open Isolator , by Region K Unit (2015-2020)
  • Table 191. Pharmaceutical Isolator Sales Closed Isolator , by Region K Unit (2015-2020)
  • Table 192. Pharmaceutical Isolator Sales: by Application(K Unit)
  • Table 193. Pharmaceutical Isolator Sales Aseptic Filling , by Region K Unit (2015-2020)
  • Table 194. Pharmaceutical Isolator Sales Fluid Dispensing , by Region K Unit (2015-2020)
  • Table 195. Pharmaceutical Isolator Sales Sampling/Weighing/Distribution , by Region K Unit (2015-2020)
  • Table 196. Pharmaceutical Isolator Sales Product Containment , by Region K Unit (2015-2020)
  • Table 197. Pharmaceutical Isolator Sales Others , by Region K Unit (2015-2020)
  • Table 198. Pharmaceutical Isolator Sales: by Product Class(K Unit)
  • Table 199. Pharmaceutical Isolator Sales Class III , by Region K Unit (2015-2020)
  • Table 200. Pharmaceutical Isolator Sales ISO Class 5 , by Region K Unit (2015-2020)
  • Table 201. Pharmaceutical Isolator Sales: by Configuration(K Unit)
  • Table 202. Pharmaceutical Isolator Sales Floor-standing , by Region K Unit (2015-2020)
  • Table 203. Pharmaceutical Isolator Sales Modular , by Region K Unit (2015-2020)
  • Table 204. Pharmaceutical Isolator Sales Mobile , by Region K Unit (2015-2020)
  • Table 205. Pharmaceutical Isolator Sales Compact , by Region K Unit (2015-2020)
  • Table 206. Pharmaceutical Isolator Sales Tabletop , by Region K Unit (2015-2020)
  • Table 207. Pharmaceutical Isolator Sales Portable , by Region K Unit (2015-2020)
  • Table 208. Pharmaceutical Isolator Sales: by Pressure(K Unit)
  • Table 209. Pharmaceutical Isolator Sales Positive Pressure , by Region K Unit (2015-2020)
  • Table 210. Pharmaceutical Isolator Sales Negative Pressure , by Region K Unit (2015-2020)
  • Table 211. Pharmaceutical Isolator Sales: by End User(K Unit)
  • Table 212. Pharmaceutical Isolator Sales Pharmaceutical & Biotechnology Companies , by Region K Unit (2015-2020)
  • Table 213. Pharmaceutical Isolator Sales Hospitals , by Region K Unit (2015-2020)
  • Table 214. Pharmaceutical Isolator Sales Research & Academic Laboratories , by Region K Unit (2015-2020)
  • Table 215. Pharmaceutical Isolator Sales Others , by Region K Unit (2015-2020)
  • Table 216. South America Pharmaceutical Isolator Sales, by Country K Unit (2015-2020)
  • Table 217. South America Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 218. South America Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 219. South America Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 220. South America Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 221. South America Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 222. South America Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 223. Brazil Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 224. Brazil Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 225. Brazil Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 226. Brazil Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 227. Brazil Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 228. Brazil Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 229. Argentina Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 230. Argentina Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 231. Argentina Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 232. Argentina Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 233. Argentina Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 234. Argentina Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 235. Rest of South America Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 236. Rest of South America Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 237. Rest of South America Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 238. Rest of South America Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 239. Rest of South America Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 240. Rest of South America Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 241. Asia Pacific Pharmaceutical Isolator Sales, by Country K Unit (2015-2020)
  • Table 242. Asia Pacific Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 243. Asia Pacific Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 244. Asia Pacific Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 245. Asia Pacific Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 246. Asia Pacific Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 247. Asia Pacific Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 248. China Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 249. China Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 250. China Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 251. China Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 252. China Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 253. China Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 254. Japan Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 255. Japan Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 256. Japan Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 257. Japan Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 258. Japan Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 259. Japan Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 260. India Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 261. India Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 262. India Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 263. India Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 264. India Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 265. India Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 266. South Korea Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 267. South Korea Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 268. South Korea Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 269. South Korea Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 270. South Korea Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 271. South Korea Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 272. Taiwan Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 273. Taiwan Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 274. Taiwan Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 275. Taiwan Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 276. Taiwan Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 277. Taiwan Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 278. Australia Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 279. Australia Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 280. Australia Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 281. Australia Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 282. Australia Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 283. Australia Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 284. Rest of Asia-Pacific Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 285. Rest of Asia-Pacific Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 286. Rest of Asia-Pacific Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 287. Rest of Asia-Pacific Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 288. Rest of Asia-Pacific Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 289. Rest of Asia-Pacific Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 290. Europe Pharmaceutical Isolator Sales, by Country K Unit (2015-2020)
  • Table 291. Europe Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 292. Europe Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 293. Europe Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 294. Europe Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 295. Europe Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 296. Europe Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 297. Germany Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 298. Germany Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 299. Germany Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 300. Germany Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 301. Germany Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 302. Germany Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 303. France Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 304. France Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 305. France Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 306. France Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 307. France Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 308. France Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 309. Italy Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 310. Italy Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 311. Italy Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 312. Italy Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 313. Italy Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 314. Italy Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 315. United Kingdom Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 316. United Kingdom Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 317. United Kingdom Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 318. United Kingdom Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 319. United Kingdom Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 320. United Kingdom Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 321. Netherlands Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 322. Netherlands Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 323. Netherlands Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 324. Netherlands Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 325. Netherlands Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 326. Netherlands Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 327. Rest of Europe Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 328. Rest of Europe Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 329. Rest of Europe Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 330. Rest of Europe Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 331. Rest of Europe Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 332. Rest of Europe Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 333. MEA Pharmaceutical Isolator Sales, by Country K Unit (2015-2020)
  • Table 334. MEA Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 335. MEA Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 336. MEA Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 337. MEA Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 338. MEA Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 339. MEA Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 340. Middle East Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 341. Middle East Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 342. Middle East Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 343. Middle East Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 344. Middle East Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 345. Middle East Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 346. Africa Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 347. Africa Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 348. Africa Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 349. Africa Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 350. Africa Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 351. Africa Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 352. North America Pharmaceutical Isolator Sales, by Country K Unit (2015-2020)
  • Table 353. North America Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 354. North America Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 355. North America Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 356. North America Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 357. North America Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 358. North America Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 359. United States Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 360. United States Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 361. United States Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 362. United States Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 363. United States Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 364. United States Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 365. Canada Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 366. Canada Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 367. Canada Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 368. Canada Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 369. Canada Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 370. Canada Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 371. Mexico Pharmaceutical Isolator Sales, by Type K Unit (2015-2020)
  • Table 372. Mexico Pharmaceutical Isolator Sales, by Application K Unit (2015-2020)
  • Table 373. Mexico Pharmaceutical Isolator Sales, by Product Class K Unit (2015-2020)
  • Table 374. Mexico Pharmaceutical Isolator Sales, by Configuration K Unit (2015-2020)
  • Table 375. Mexico Pharmaceutical Isolator Sales, by Pressure K Unit (2015-2020)
  • Table 376. Mexico Pharmaceutical Isolator Sales, by End User K Unit (2015-2020)
  • Table 377. Pharmaceutical Isolator: by Type(USD/Units)
  • Table 378. Company Basic Information, Sales Area and Its Competitors
  • Table 379. Company Basic Information, Sales Area and Its Competitors
  • Table 380. Company Basic Information, Sales Area and Its Competitors
  • Table 381. Company Basic Information, Sales Area and Its Competitors
  • Table 382. Company Basic Information, Sales Area and Its Competitors
  • Table 383. Company Basic Information, Sales Area and Its Competitors
  • Table 384. Company Basic Information, Sales Area and Its Competitors
  • Table 385. Company Basic Information, Sales Area and Its Competitors
  • Table 386. Company Basic Information, Sales Area and Its Competitors
  • Table 387. Company Basic Information, Sales Area and Its Competitors
  • Table 388. Company Basic Information, Sales Area and Its Competitors
  • Table 389. Pharmaceutical Isolator: by Type(USD Million)
  • Table 390. Pharmaceutical Isolator Open Isolator , by Region USD Million (2021-2026)
  • Table 391. Pharmaceutical Isolator Closed Isolator , by Region USD Million (2021-2026)
  • Table 392. Pharmaceutical Isolator: by Application(USD Million)
  • Table 393. Pharmaceutical Isolator Aseptic Filling , by Region USD Million (2021-2026)
  • Table 394. Pharmaceutical Isolator Fluid Dispensing , by Region USD Million (2021-2026)
  • Table 395. Pharmaceutical Isolator Sampling/Weighing/Distribution , by Region USD Million (2021-2026)
  • Table 396. Pharmaceutical Isolator Product Containment , by Region USD Million (2021-2026)
  • Table 397. Pharmaceutical Isolator Others , by Region USD Million (2021-2026)
  • Table 398. Pharmaceutical Isolator: by Product Class(USD Million)
  • Table 399. Pharmaceutical Isolator Class III , by Region USD Million (2021-2026)
  • Table 400. Pharmaceutical Isolator ISO Class 5 , by Region USD Million (2021-2026)
  • Table 401. Pharmaceutical Isolator: by Configuration(USD Million)
  • Table 402. Pharmaceutical Isolator Floor-standing , by Region USD Million (2021-2026)
  • Table 403. Pharmaceutical Isolator Modular , by Region USD Million (2021-2026)
  • Table 404. Pharmaceutical Isolator Mobile , by Region USD Million (2021-2026)
  • Table 405. Pharmaceutical Isolator Compact , by Region USD Million (2021-2026)
  • Table 406. Pharmaceutical Isolator Tabletop , by Region USD Million (2021-2026)
  • Table 407. Pharmaceutical Isolator Portable , by Region USD Million (2021-2026)
  • Table 408. Pharmaceutical Isolator: by Pressure(USD Million)
  • Table 409. Pharmaceutical Isolator Positive Pressure , by Region USD Million (2021-2026)
  • Table 410. Pharmaceutical Isolator Negative Pressure , by Region USD Million (2021-2026)
  • Table 411. Pharmaceutical Isolator: by End User(USD Million)
  • Table 412. Pharmaceutical Isolator Pharmaceutical & Biotechnology Companies , by Region USD Million (2021-2026)
  • Table 413. Pharmaceutical Isolator Hospitals , by Region USD Million (2021-2026)
  • Table 414. Pharmaceutical Isolator Research & Academic Laboratories , by Region USD Million (2021-2026)
  • Table 415. Pharmaceutical Isolator Others , by Region USD Million (2021-2026)
  • Table 416. South America Pharmaceutical Isolator, by Country USD Million (2021-2026)
  • Table 417. South America Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 418. South America Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 419. South America Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 420. South America Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 421. South America Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 422. South America Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 423. Brazil Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 424. Brazil Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 425. Brazil Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 426. Brazil Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 427. Brazil Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 428. Brazil Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 429. Argentina Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 430. Argentina Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 431. Argentina Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 432. Argentina Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 433. Argentina Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 434. Argentina Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 435. Rest of South America Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 436. Rest of South America Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 437. Rest of South America Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 438. Rest of South America Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 439. Rest of South America Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 440. Rest of South America Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 441. Asia Pacific Pharmaceutical Isolator, by Country USD Million (2021-2026)
  • Table 442. Asia Pacific Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 443. Asia Pacific Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 444. Asia Pacific Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 445. Asia Pacific Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 446. Asia Pacific Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 447. Asia Pacific Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 448. China Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 449. China Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 450. China Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 451. China Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 452. China Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 453. China Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 454. Japan Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 455. Japan Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 456. Japan Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 457. Japan Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 458. Japan Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 459. Japan Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 460. India Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 461. India Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 462. India Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 463. India Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 464. India Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 465. India Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 466. South Korea Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 467. South Korea Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 468. South Korea Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 469. South Korea Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 470. South Korea Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 471. South Korea Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 472. Taiwan Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 473. Taiwan Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 474. Taiwan Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 475. Taiwan Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 476. Taiwan Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 477. Taiwan Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 478. Australia Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 479. Australia Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 480. Australia Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 481. Australia Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 482. Australia Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 483. Australia Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 484. Rest of Asia-Pacific Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 485. Rest of Asia-Pacific Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 486. Rest of Asia-Pacific Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 487. Rest of Asia-Pacific Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 488. Rest of Asia-Pacific Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 489. Rest of Asia-Pacific Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 490. Europe Pharmaceutical Isolator, by Country USD Million (2021-2026)
  • Table 491. Europe Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 492. Europe Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 493. Europe Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 494. Europe Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 495. Europe Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 496. Europe Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 497. Germany Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 498. Germany Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 499. Germany Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 500. Germany Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 501. Germany Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 502. Germany Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 503. France Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 504. France Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 505. France Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 506. France Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 507. France Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 508. France Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 509. Italy Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 510. Italy Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 511. Italy Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 512. Italy Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 513. Italy Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 514. Italy Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 515. United Kingdom Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 516. United Kingdom Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 517. United Kingdom Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 518. United Kingdom Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 519. United Kingdom Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 520. United Kingdom Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 521. Netherlands Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 522. Netherlands Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 523. Netherlands Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 524. Netherlands Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 525. Netherlands Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 526. Netherlands Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 527. Rest of Europe Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 528. Rest of Europe Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 529. Rest of Europe Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 530. Rest of Europe Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 531. Rest of Europe Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 532. Rest of Europe Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 533. MEA Pharmaceutical Isolator, by Country USD Million (2021-2026)
  • Table 534. MEA Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 535. MEA Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 536. MEA Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 537. MEA Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 538. MEA Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 539. MEA Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 540. Middle East Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 541. Middle East Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 542. Middle East Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 543. Middle East Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 544. Middle East Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 545. Middle East Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 546. Africa Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 547. Africa Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 548. Africa Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 549. Africa Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 550. Africa Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 551. Africa Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 552. North America Pharmaceutical Isolator, by Country USD Million (2021-2026)
  • Table 553. North America Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 554. North America Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 555. North America Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 556. North America Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 557. North America Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 558. North America Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 559. United States Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 560. United States Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 561. United States Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 562. United States Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 563. United States Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 564. United States Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 565. Canada Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 566. Canada Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 567. Canada Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 568. Canada Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 569. Canada Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 570. Canada Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 571. Mexico Pharmaceutical Isolator, by Type USD Million (2021-2026)
  • Table 572. Mexico Pharmaceutical Isolator, by Application USD Million (2021-2026)
  • Table 573. Mexico Pharmaceutical Isolator, by Product Class USD Million (2021-2026)
  • Table 574. Mexico Pharmaceutical Isolator, by Configuration USD Million (2021-2026)
  • Table 575. Mexico Pharmaceutical Isolator, by Pressure USD Million (2021-2026)
  • Table 576. Mexico Pharmaceutical Isolator, by End User USD Million (2021-2026)
  • Table 577. Pharmaceutical Isolator Sales: by Type(K Unit)
  • Table 578. Pharmaceutical Isolator Sales Open Isolator , by Region K Unit (2021-2026)
  • Table 579. Pharmaceutical Isolator Sales Closed Isolator , by Region K Unit (2021-2026)
  • Table 580. Pharmaceutical Isolator Sales: by Application(K Unit)
  • Table 581. Pharmaceutical Isolator Sales Aseptic Filling , by Region K Unit (2021-2026)
  • Table 582. Pharmaceutical Isolator Sales Fluid Dispensing , by Region K Unit (2021-2026)
  • Table 583. Pharmaceutical Isolator Sales Sampling/Weighing/Distribution , by Region K Unit (2021-2026)
  • Table 584. Pharmaceutical Isolator Sales Product Containment , by Region K Unit (2021-2026)
  • Table 585. Pharmaceutical Isolator Sales Others , by Region K Unit (2021-2026)
  • Table 586. Pharmaceutical Isolator Sales: by Product Class(K Unit)
  • Table 587. Pharmaceutical Isolator Sales Class III , by Region K Unit (2021-2026)
  • Table 588. Pharmaceutical Isolator Sales ISO Class 5 , by Region K Unit (2021-2026)
  • Table 589. Pharmaceutical Isolator Sales: by Configuration(K Unit)
  • Table 590. Pharmaceutical Isolator Sales Floor-standing , by Region K Unit (2021-2026)
  • Table 591. Pharmaceutical Isolator Sales Modular , by Region K Unit (2021-2026)
  • Table 592. Pharmaceutical Isolator Sales Mobile , by Region K Unit (2021-2026)
  • Table 593. Pharmaceutical Isolator Sales Compact , by Region K Unit (2021-2026)
  • Table 594. Pharmaceutical Isolator Sales Tabletop , by Region K Unit (2021-2026)
  • Table 595. Pharmaceutical Isolator Sales Portable , by Region K Unit (2021-2026)
  • Table 596. Pharmaceutical Isolator Sales: by Pressure(K Unit)
  • Table 597. Pharmaceutical Isolator Sales Positive Pressure , by Region K Unit (2021-2026)
  • Table 598. Pharmaceutical Isolator Sales Negative Pressure , by Region K Unit (2021-2026)
  • Table 599. Pharmaceutical Isolator Sales: by End User(K Unit)
  • Table 600. Pharmaceutical Isolator Sales Pharmaceutical & Biotechnology Companies , by Region K Unit (2021-2026)
  • Table 601. Pharmaceutical Isolator Sales Hospitals , by Region K Unit (2021-2026)
  • Table 602. Pharmaceutical Isolator Sales Research & Academic Laboratories , by Region K Unit (2021-2026)
  • Table 603. Pharmaceutical Isolator Sales Others , by Region K Unit (2021-2026)
  • Table 604. South America Pharmaceutical Isolator Sales, by Country K Unit (2021-2026)
  • Table 605. South America Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 606. South America Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 607. South America Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 608. South America Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 609. South America Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 610. South America Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 611. Brazil Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 612. Brazil Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 613. Brazil Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 614. Brazil Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 615. Brazil Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 616. Brazil Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 617. Argentina Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 618. Argentina Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 619. Argentina Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 620. Argentina Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 621. Argentina Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 622. Argentina Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 623. Rest of South America Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 624. Rest of South America Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 625. Rest of South America Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 626. Rest of South America Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 627. Rest of South America Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 628. Rest of South America Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 629. Asia Pacific Pharmaceutical Isolator Sales, by Country K Unit (2021-2026)
  • Table 630. Asia Pacific Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 631. Asia Pacific Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 632. Asia Pacific Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 633. Asia Pacific Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 634. Asia Pacific Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 635. Asia Pacific Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 636. China Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 637. China Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 638. China Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 639. China Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 640. China Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 641. China Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 642. Japan Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 643. Japan Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 644. Japan Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 645. Japan Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 646. Japan Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 647. Japan Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 648. India Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 649. India Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 650. India Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 651. India Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 652. India Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 653. India Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 654. South Korea Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 655. South Korea Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 656. South Korea Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 657. South Korea Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 658. South Korea Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 659. South Korea Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 660. Taiwan Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 661. Taiwan Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 662. Taiwan Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 663. Taiwan Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 664. Taiwan Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 665. Taiwan Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 666. Australia Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 667. Australia Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 668. Australia Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 669. Australia Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 670. Australia Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 671. Australia Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 672. Rest of Asia-Pacific Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 673. Rest of Asia-Pacific Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 674. Rest of Asia-Pacific Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 675. Rest of Asia-Pacific Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 676. Rest of Asia-Pacific Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 677. Rest of Asia-Pacific Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 678. Europe Pharmaceutical Isolator Sales, by Country K Unit (2021-2026)
  • Table 679. Europe Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 680. Europe Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 681. Europe Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 682. Europe Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 683. Europe Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 684. Europe Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 685. Germany Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 686. Germany Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 687. Germany Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 688. Germany Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 689. Germany Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 690. Germany Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 691. France Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 692. France Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 693. France Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 694. France Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 695. France Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 696. France Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 697. Italy Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 698. Italy Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 699. Italy Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 700. Italy Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 701. Italy Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 702. Italy Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 703. United Kingdom Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 704. United Kingdom Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 705. United Kingdom Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 706. United Kingdom Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 707. United Kingdom Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 708. United Kingdom Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 709. Netherlands Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 710. Netherlands Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
  • Table 711. Netherlands Pharmaceutical Isolator Sales, by Product Class K Unit (2021-2026)
  • Table 712. Netherlands Pharmaceutical Isolator Sales, by Configuration K Unit (2021-2026)
  • Table 713. Netherlands Pharmaceutical Isolator Sales, by Pressure K Unit (2021-2026)
  • Table 714. Netherlands Pharmaceutical Isolator Sales, by End User K Unit (2021-2026)
  • Table 715. Rest of Europe Pharmaceutical Isolator Sales, by Type K Unit (2021-2026)
  • Table 716. Rest of Europe Pharmaceutical Isolator Sales, by Application K Unit (2021-2026)
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmaceutical Isolator: by Type USD Million (2015-2020)
  • Figure 5. Global Pharmaceutical Isolator: by Application USD Million (2015-2020)
  • Figure 6. Global Pharmaceutical Isolator: by Product Class USD Million (2015-2020)
  • Figure 7. Global Pharmaceutical Isolator: by Configuration USD Million (2015-2020)
  • Figure 8. Global Pharmaceutical Isolator: by Pressure USD Million (2015-2020)
  • Figure 9. Global Pharmaceutical Isolator: by End User USD Million (2015-2020)
  • Figure 10. South America Pharmaceutical Isolator Share (%), by Country
  • Figure 11. Asia Pacific Pharmaceutical Isolator Share (%), by Country
  • Figure 12. Europe Pharmaceutical Isolator Share (%), by Country
  • Figure 13. MEA Pharmaceutical Isolator Share (%), by Country
  • Figure 14. North America Pharmaceutical Isolator Share (%), by Country
  • Figure 15. Global Pharmaceutical Isolator: by Type K Unit (2015-2020)
  • Figure 16. Global Pharmaceutical Isolator: by Application K Unit (2015-2020)
  • Figure 17. Global Pharmaceutical Isolator: by Product Class K Unit (2015-2020)
  • Figure 18. Global Pharmaceutical Isolator: by Configuration K Unit (2015-2020)
  • Figure 19. Global Pharmaceutical Isolator: by Pressure K Unit (2015-2020)
  • Figure 20. Global Pharmaceutical Isolator: by End User K Unit (2015-2020)
  • Figure 21. South America Pharmaceutical Isolator Share (%), by Country
  • Figure 22. Asia Pacific Pharmaceutical Isolator Share (%), by Country
  • Figure 23. Europe Pharmaceutical Isolator Share (%), by Country
  • Figure 24. MEA Pharmaceutical Isolator Share (%), by Country
  • Figure 25. North America Pharmaceutical Isolator Share (%), by Country
  • Figure 26. Global Pharmaceutical Isolator: by Type USD/Units (2015-2020)
  • Figure 27. Global Pharmaceutical Isolator share by Players 2020 (%)
  • Figure 28. Global Pharmaceutical Isolator share by Players (Top 3) 2020(%)
  • Figure 29. Global Pharmaceutical Isolator share by Players (Top 5) 2020(%)
  • Figure 30. BCG Matrix for key Companies
  • Figure 31. SKAN AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. SKAN AG (Switzerland) Revenue: by Geography 2020
  • Figure 33. Azbil Telstar (India) Revenue, Net Income and Gross profit
  • Figure 34. Azbil Telstar (India) Revenue: by Geography 2020
  • Figure 35. VanRx Pharmasystems Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 36. VanRx Pharmasystems Inc. (Canada) Revenue: by Geography 2020
  • Figure 37. NuAire Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. NuAire Inc. (United States) Revenue: by Geography 2020
  • Figure 39. Schematic Engineering Industries (India) Revenue, Net Income and Gross profit
  • Figure 40. Schematic Engineering Industries (India) Revenue: by Geography 2020
  • Figure 41. MBRAUN (Germany) Revenue, Net Income and Gross profit
  • Figure 42. MBRAUN (Germany) Revenue: by Geography 2020
  • Figure 43. Robert Bosch GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 44. Robert Bosch GmbH (Germany) Revenue: by Geography 2020
  • Figure 45. Hosokawa Micron Ltd (Japan) Revenue, Net Income and Gross profit
  • Figure 46. Hosokawa Micron Ltd (Japan) Revenue: by Geography 2020
  • Figure 47. Fedegari Autoclavi SpA (Italy) Revenue, Net Income and Gross profit
  • Figure 48. Fedegari Autoclavi SpA (Italy) Revenue: by Geography 2020
  • Figure 49. LAF Technologies Pty Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 50. LAF Technologies Pty Ltd. (Australia) Revenue: by Geography 2020
  • Figure 51. IsoTech Design (Canada) Revenue, Net Income and Gross profit
  • Figure 52. IsoTech Design (Canada) Revenue: by Geography 2020
  • Figure 53. Global Pharmaceutical Isolator: by Type USD Million (2021-2026)
  • Figure 54. Global Pharmaceutical Isolator: by Application USD Million (2021-2026)
  • Figure 55. Global Pharmaceutical Isolator: by Product Class USD Million (2021-2026)
  • Figure 56. Global Pharmaceutical Isolator: by Configuration USD Million (2021-2026)
  • Figure 57. Global Pharmaceutical Isolator: by Pressure USD Million (2021-2026)
  • Figure 58. Global Pharmaceutical Isolator: by End User USD Million (2021-2026)
  • Figure 59. South America Pharmaceutical Isolator Share (%), by Country
  • Figure 60. Asia Pacific Pharmaceutical Isolator Share (%), by Country
  • Figure 61. Europe Pharmaceutical Isolator Share (%), by Country
  • Figure 62. MEA Pharmaceutical Isolator Share (%), by Country
  • Figure 63. North America Pharmaceutical Isolator Share (%), by Country
  • Figure 64. Global Pharmaceutical Isolator: by Type K Unit (2021-2026)
  • Figure 65. Global Pharmaceutical Isolator: by Application K Unit (2021-2026)
  • Figure 66. Global Pharmaceutical Isolator: by Product Class K Unit (2021-2026)
  • Figure 67. Global Pharmaceutical Isolator: by Configuration K Unit (2021-2026)
  • Figure 68. Global Pharmaceutical Isolator: by Pressure K Unit (2021-2026)
  • Figure 69. Global Pharmaceutical Isolator: by End User K Unit (2021-2026)
  • Figure 70. South America Pharmaceutical Isolator Share (%), by Country
  • Figure 71. Asia Pacific Pharmaceutical Isolator Share (%), by Country
  • Figure 72. Europe Pharmaceutical Isolator Share (%), by Country
  • Figure 73. MEA Pharmaceutical Isolator Share (%), by Country
  • Figure 74. North America Pharmaceutical Isolator Share (%), by Country
  • Figure 75. Global Pharmaceutical Isolator: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • SKAN AG (Switzerland)
  • Azbil Telstar (India)
  • VanRx Pharmasystems Inc. (Canada)
  • NuAire Inc. (United States)
  • Schematic Engineering Industries (India)
  • MBRAUN (Germany)
  • Robert Bosch GmbH (Germany)
  • Hosokawa Micron Ltd (Japan)
  • Fedegari Autoclavi SpA (Italy)
  • LAF Technologies Pty Ltd. (Australia)
  • IsoTech Design (Canada)
Additional players considered in the study are as follows:
Comecer (Italy) , Gelman Singapore Pte Ltd. (Singapore)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation